You are here: Welcome to the MPKB » Welcome to the MPKB » Marshall Protocol » Managing immunopathology (IP)
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
home:mp:managing_immunopathology [12.15.2018] – [Strategy #8: examine Magnesium status] new section sallieqhome:mp:managing_immunopathology [02.11.2019] – [Strategy #5: Take guaifenesin] sallieq
Line 127: Line 127:
 ==== Strategy #5: Take guaifenesin ==== ==== Strategy #5: Take guaifenesin ====
  
-The expectorant [[home:othertreatments:guaifenesin|guaifenesin]] may help dampen inflammation a bit as well as liquefy mucus. Use a product that does not contain any other ingredients. One might find a slight surge of symptoms during "withdrawal" from periods of intense guaifenesin use.+The expectorant [[home:othertreatments:guaifenesin|Guaifenesin]] may help dampen inflammation a bit as well as liquefy mucus. Use a product that does not contain any other ingredients. One might find a slight surge of symptoms during "withdrawal" from periods of intense guaifenesin use.
 ==== Strategy #6: Re-examine food/supplement/medication intake and changes in response to light ==== ==== Strategy #6: Re-examine food/supplement/medication intake and changes in response to light ====
  
home/mp/managing_immunopathology.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.